FRAMINGHAM (01/15/2004) - Johnson & Johnson Pharmaceutical Research Development is widening its collaboration with Entelos to include target validation, lead optimization, and clinical development in the area of obesity. Their investigations will involve use of Entelos' Metabolism PhysioLab, a mathematical model of human pathophysiology for simulating experiments and trials.
- Free Whitepaper! Learn how to create an analytics environment that is governed, scalable and self-serve.
- Free Whitepaper! The 5 criteria to help you select the right analytics platform for your organization.
- Free Whitepaper! Learn how IT is evolving from producer to enabler, and fostering collaboration around analytics.